<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T09:57:59Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/110903" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/110903</identifier><datestamp>2026-05-15T19:49:52Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Harlan, Blaine</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair">Soloway, Paul</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Danko, Charles G.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Cummings, Bethany P.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Roberson, Mark Stephen</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2022-01-24T18:08:16Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2022-01-24T18:08:16Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2021-12</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Submission ID: 12786</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Publication ID: 28719033</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/110903</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="doi">https://doi.org/10.7298/54pa-pt53</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">15312758</dim:field>
   <dim:field mdschema="dc" element="description">114 pages</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Many adverse health outcomes result from dysregulation of cellular processes such as cell-cell signaling, transcription, protein modifications, and cellular metabolism. This includes obesity, leading to detrimental health outcomes involving type 2 diabetes and cardiometabolic disease. Vertical sleeve gastrectomy (VSG), a surgical obesity treatment, results in long-term weight loss and remission of type 2 diabetes in most patients. Some effects of VSG are independent of body weight, and the mechanisms behind the metabolic benefits are not fully understood. I performed single-nucleus ATAC-seq on adipose tissues from a VSG mouse model to reveal the mechanisms regulating adipose tissue and its contribution to the VSG-induced metabolic improvements. We observed depot-specific cellular composition and chromatin accessibility patterns altered by VSG. In particular, VSG reduced the accessibility of Scd1, which encodes a fatty acid desaturase. Additionally, SCD1-produced monounsaturated fatty acids were less abundant, meaning SCD1 activity was reduced. Obesity and insulin resistance are positively correlated with SCD1 activity, suggesting that the VSG-induced reduction in accessibility and activity of SCD1 acts as a metabolic switch in adipocytes, potentially leading to whole-body insulin sensitivity. These findings provide insights into how alterations to adipose lipid metabolism could contribute to the beneficial effects of VSG.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="rights">Attribution 4.0 International</dim:field>
   <dim:field mdschema="dc" element="rights" qualifier="uri">https://creativecommons.org/licenses/by/4.0/</dim:field>
   <dim:field mdschema="dc" element="subject">Adipocyte</dim:field>
   <dim:field mdschema="dc" element="subject">Adipose</dim:field>
   <dim:field mdschema="dc" element="subject">ATAC-seq</dim:field>
   <dim:field mdschema="dc" element="subject">SCD1</dim:field>
   <dim:field mdschema="dc" element="subject">Single-cell sequencing</dim:field>
   <dim:field mdschema="dc" element="subject">Vertical Sleeve Gastrectomy</dim:field>
   <dim:field mdschema="dc" element="title">CHROMATIN ACCESSIBILITY CHANGES IN ADIPOSE TISSUE CONTRIBUTING TO THE METABOLIC BENEFITS OF BARIATRIC SURGERY</dim:field>
   <dim:field mdschema="dc" element="type">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="localuri">https://newcatalog.library.cornell.edu/catalog/15312758</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Genetics, Genomics and Development</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Genetics, Genomics and Development</dim:field>
   <dim:field mdschema="dcterms" element="license">https://hdl.handle.net/1813/59810.2</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://cornell-ecommons.eks.prod.4science.cloud/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author">Harlan, Blaine</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="d128e7a6-61b8-4515-8f39-c659ec844642">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en&lt;/Language>
   	&lt;Title>CHROMATIN ACCESSIBILITY CHANGES IN ADIPOSE TISSUE CONTRIBUTING TO THE METABOLIC BENEFITS OF BARIATRIC SURGERY&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2021-12&lt;/PublicationDate>
   	&lt;DOI>https://doi.org/10.7298/54pa-pt53&lt;/DOI>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Harlan, Blaine&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;License>https://creativecommons.org/licenses/by/4.0/&lt;/License>
    &lt;Keyword>Adipocyte&lt;/Keyword>
    &lt;Keyword>Adipose&lt;/Keyword&gt;
    &lt;Keyword>ATAC-seq&lt;/Keyword>
    &lt;Keyword>SCD1&lt;/Keyword>
    &lt;Keyword>Single-cell sequencing&lt;/Keyword>
    &lt;Keyword>Vertical Sleeve Gastrectomy&lt;/Keyword>
   	&lt;Abstract>Many adverse health outcomes result from dysregulation of cellular processes such as cell-cell signaling, transcription, protein modifications, and cellular metabolism. This includes obesity, leading to detrimental health outcomes involving type 2 diabetes and cardiometabolic disease. Vertical sleeve gastrectomy (VSG), a surgical obesity treatment, results in long-term weight loss and remission of type 2 diabetes in most patients. Some effects of VSG are independent of body weight, and the mechanisms behind the metabolic benefits are not fully understood. I performed single-nucleus ATAC-seq on adipose tissues from a VSG mouse model to reveal the mechanisms regulating adipose tissue and its contribution to the VSG-induced metabolic improvements. We observed depot-specific cellular composition and chromatin accessibility patterns altered by VSG. In particular, VSG reduced the accessibility of Scd1, which encodes a fatty acid desaturase. Additionally, SCD1-produced monounsaturated fatty acids were less abundant, meaning SCD1 activity was reduced. Obesity and insulin resistance are positively correlated with SCD1 activity, suggesting that the VSG-induced reduction in accessibility and activity of SCD1 acts as a metabolic switch in adipocytes, potentially leading to whole-body insulin sensitivity. These findings provide insights into how alterations to adipose lipid metabolism could contribute to the beneficial effects of VSG.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>